US Patent Issued to Hepion Pharmaceuticals on Sept. 9 for "Use of cyclosporine analogues for treating fibrosis" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,206, issued on Sept. 9, was assigned to Hepion Pharmaceuticals Inc. (Edison, N.J.).

"Use of cyclosporine analogues for treating fibrosis" was invented by Daren R. Ure (Edmonton, Canada), Daniel J. Trepanier (Edmonton, Canada), Patrick R. Mayo (Edmonton, Canada) and Robert T. Foster (Edmonton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein include methods, compositions, and kits suitable for use in preventing, treating or reverse fibrosis. The methods comprise administering to a subject in need thereof a composition comprising a cyclosporine analogue (for example, CRV431), or a pharmaceutically acceptable salt, solvate, stere...